More on NGNE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neurogene (NQ:NGNE)
Delayed: 37.31 +0.81 (2.22%)
Prev. Close $36.50  
Open$35.49 
52 Wk High$ 
52 Wk Low$ 
Day High$38.25 
Day Low$35.05 
P/E N/A  
EPS$ 
Volume473,445 

Friends, Peers and Foes (?): TSHA (more...)

Jul 7, 2026 09:08 PM Form 4 Neurogene Inc. For: Jul 06 Filed by: Cvijic Christine Mikail
Jul 6, 2026 04:01 PM Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 2, 2026 06:43 PM Form 4 Neurogene Inc. For: Jul 01 Filed by: Cvijic Christine Mikail
Jul 2, 2026 06:04 AM Form 8-K Neurogene Inc. For: Jun 30
Jul 2, 2026 06:04 AM Form 424B5 Neurogene Inc.
Jul 2, 2026 04:19 AM Taysha Gene Therapies (TSHA) Reiterated at Market Outperform by Citizens
Jul 1, 2026 02:38 PM Neurogene (NGNE) PT Raised to $77 at Leerink
Jul 1, 2026 07:00 AM Neurogene prices $125 million public offering at $30 per share
Jul 1, 2026 07:00 AM Neurogene Inc. Announces Pricing of $125 Million Public Offering
Jun 30, 2026 04:19 PM Form 424B5 Neurogene Inc.
View All Articles

Entities mentioned with NGNE

View All Entities